These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7171456)

  • 1. Doubling time of circulating cea and its relation to survival of patients with recurrent colorectal cancer.
    Staab HJ; Anderer FA; Hornung A; Stumpf E; Fischer R
    Br J Cancer; 1982 Nov; 46(5):773-81. PubMed ID: 7171456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The doubling time of circulating CEA as an individual prognostic criterion of recurrence in patients with gastrointestinal cancers].
    Brümmendorf T; Anderer FA; Staab HJ; Hornung A; Kieninger G
    Klin Wochenschr; 1986 Jan; 64(2):63-9. PubMed ID: 3951166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating carcinoembryonic antigen (CEA), a growth parameter in malignant disease.
    Staab HJ; Anderer FA
    Cancer Detect Prev; 1983; 6(1-2):33-9. PubMed ID: 6883391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum carcinoembryonic antigen doubling time in patients with recurrent gastrointestinal carcinoma and its relationship to tumor biology and life expectancy].
    Takesue F; Inutsuka S; Nagahama S; Kusumoto H; Korenaga D; Maekawa S; Ikeda T
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():464-8. PubMed ID: 9589054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of CEA in colorectal carcinoma].
    Shimoyama T; Fukuda Y; Itoh S; Shimizu T; Kawaguchi A; Mori M; Ishii T; Miura T; Tomita M
    Gan No Rinsho; 1985 May; 31(6 Suppl):648-54. PubMed ID: 3897618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distributions in CEA doubling time differ in patients with recurrent colorectal carcinomas.
    Yamamoto M; Maehara Y; Sakaguchi Y; Mine H; Yamanaka T; Korenaga D; Okamura T
    Hepatogastroenterology; 2004; 51(55):147-51. PubMed ID: 15011851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of doubling times of serum carcinoembryonic antigen produced by various metastatic lesions in recurrent gastric and colorectal carcinomas.
    Umehara Y; Kimura T; Yoshida M; Oba N; Harada Y
    Cancer; 1993 Jun; 71(12):4055-9. PubMed ID: 8508370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancer.
    Wood CB; Ratcliffe JG; Burt RW; Malcolm AJ; Blumgart LH
    Br J Surg; 1980 Jan; 67(1):46-8. PubMed ID: 7357243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of adenocarcinomas of the colorectum with low levels of preoperative plasma carcinoembryonic antigen (CEA).
    Jubert AV; Talbott TM; Maycroft TM
    Cancer; 1978 Aug; 42(2):635-9. PubMed ID: 679156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of analytical CEA doubling time and half-life time for overlooked synchronous metastases in colorectal carcinoma.
    Ito K; Hibi K; Ando H; Hidemura K; Yamazaki T; Akiyama S; Nakao A
    Jpn J Clin Oncol; 2002 Feb; 32(2):54-8. PubMed ID: 11948229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer?
    Wanebo HJ
    Surgery; 1981 Mar; 89(3):290-5. PubMed ID: 7466616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the reliability of carcinoembryonic antigen blood levels in following the course of colorectal cancer.
    Armitage NC; Davidson A; Tsikos D; Wood CB
    Clin Oncol; 1984 Jun; 10(2):141-7. PubMed ID: 6375928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective evaluation of serum carcinoembryonic antigen (CEA) levels in the management of colorectal carcinoma.
    Boey J; Cheung HC; Lai CK; Wong J
    World J Surg; 1984 Jun; 8(3):279-86. PubMed ID: 6464483
    [No Abstract]   [Full Text] [Related]  

  • 14. Carcinoembryonic antigen (CEA) and alkaline phosphatase in progressive colorectal cancer with special reference to patient survival.
    Aabo K; Pedersen H; Kjaer M
    Eur J Cancer Clin Oncol; 1986 Feb; 22(2):211-7. PubMed ID: 3699082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Using CEA for diagnostic, therapeutic and prognostic evaluation in colorectal cancers].
    Terabe K; Ichihashi H; Kamei H; Kondo T
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):111-6. PubMed ID: 6696454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CEA levels at recurrence and metastases; importance for detecting secondary disease.
    Rieger A; Wahren B
    Scand J Gastroenterol; 1975; 10(8):869-74. PubMed ID: 1202621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of combined CA-19-9 and CEA assay in monitoring recurrences and metastases of colorectal cancer].
    Yu BM
    Zhonghua Wai Ke Za Zhi; 1992 Dec; 30(12):707-9, 777. PubMed ID: 1339738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CEA assays in postoperative detection of recurrent colorectal carcinoma (author's transl)].
    Kato K; Morimoto T; Kato T; Yasue M; Takagi H; Kito T; Nakazato H; Miyaishi S; Yamada E; Kuwabara M; Suchi T
    Nihon Gan Chiryo Gakkai Shi; 1980 Dec; 15(7):1137-42. PubMed ID: 7229472
    [No Abstract]   [Full Text] [Related]  

  • 19. Doubling time of carcinoembryonic antigen is a significant prognostic factor after the surgical resection of locally recurrent rectal cancer.
    Tanaka K; Noura S; Ohue M; Seki Y; Yamada T; Miyashiro I; Ohigashi H; Yano M; Ishikawa O; Murata K; Kameyama M; Imaoka S
    Dig Surg; 2008; 25(4):319-24. PubMed ID: 18818499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic value of tumor markers in cases of colorectal cancer: CEA and CA 19-9].
    Desaive C; Servais R; Collette J; Denis D; Reginster JY; Franchimont P
    Acta Gastroenterol Belg; 1987; 50(1):65-78. PubMed ID: 3480671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.